🎯
LATEST VERIFIED ALGORITHMIC EXECUTION
Quantitative engine captured a net profit of +19.26% on $OC in just 23h 32m.
EWT
$EWTX
🔒 US EquitiesEdgewise Therapeutics Inc
AVG HISTORICAL GAP
-0.20%
MAX GAP RECORD
-4.50%
🔒 PRO INSTITUTIONAL
AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡
SENTINEL HISTORICAL GAP VIEWER
// $EWTX
📊 1-YEAR TIMELINE (GAPS PLOTTED)
🔮 SIMULATE SETUP 🔒
GAP INSPECTION // PLAYBACK PROTOCOL
$EWTX
HISTORICAL GAP OCCURRENCE
Analyzing price jump between T-1 close and opening auction.
EVENT DATE—
GAP MAGNITUDE—
T-1 CLOSE—
OPEN PRICE—
AI DIRECTIONPRO ONLY 🔒
Bullish Opening Gap
Bearish Opening Gap
T-1 Close Baseline
CATALYSTS & GAP HISTORY
| Nov 05, 2026 Earnings Release 2026-11-05 (BEFORE OPEN (07:00)) | 🔮 UPCOMING 🔒 |
| Aug 06, 2026 Earnings Release 2026-08-06 (BEFORE OPEN) |
-1.91%
|
| May 07, 2026 Earnings Release 2026-05-07 (BEFORE OPEN) |
+2.73%
|
| Feb 26, 2026 Earnings Release 2026-02-26 (BEFORE OPEN) |
-0.73%
|
| Nov 06, 2025 Earnings Release 2025-11-06 (BEFORE OPEN) |
+1.27%
|
| Aug 07, 2025 Earnings Release 2025-08-07 (BEFORE OPEN) |
+2.92%
|
| May 07, 2025 Earnings Release 2025-05-07 (BEFORE OPEN) |
+0.28%
|
| Mar 03, 2025 Earnings Release 2025-03-03 (BEFORE OPEN) |
-1.45%
|
VOLATILITY & GAP BIAS
AVG GAP MOVE
1.5%
Bullish Gaps (4)
Bearish Gaps (5)
Neutral / Flat (6)
📖 Intelligence Summary
Edgewise Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The firm focuses on the discovery, development and commercialization of innovative treatments for severe, rare muscle disorders for which there is significant unmet medical need. Its platform utilizes custom-built throughput and translatable systems that measure integrated muscle function in whole organ extracts…
NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗